The New Jersey Alliance for Clinical and Translational Science (NJ ACTS) is committed to advancing clinical and translational science to develop new therapies and treatments and improve health and health care in New Jersey. A consortium coordinated by Rutgers Biomedical and Health Sciences, NJ ACTS includes Rutgers and Princeton Universities, NJ Institute for Technology (NJIT), medical, nursing, dental and public health schools, hospitals, community health centers, outpatient practices, industry, policymakers and health information exchanges. A unique combination of institutions, NJ ACTS is committed to community engagement, ensuring that New Jersyans are partners in our research through patient advocacy and community partnerships.